Figure 4.
Determining pathogenicity of novel CNM variants by various analyses. Possible phenotypic summary of unknown variants identified from CNM patients analysed by various assays either in vitro (GTPase activity) or in cellulo (DNM2 aggregation and TLS formation) to determine their pathogenicity. N: nuclei.